Caveolin-1 and Sox-2 are predictive biomarkers of cetuximab response in head and neck cancer
Mehdi Bouhaddou(QB3), Jennifer R. Grandis(University of California, San Francisco), Neil E. Bhola(University of California, San Francisco), Rex H. Lee, Adam B. Olshen(University of California, San Francisco), Scott Vandenberg(The University of Texas MD Anderson Cancer Center), Nevan J. Krogan(QB3), Aaron Hechmer(UCSF Helen Diller Family Comprehensive Cancer Center), Stephen B. Keysar(University of Colorado Denver), Umamaheswar Duvvuri(City University of New York), Daniel E. Johnson(UCSF Helen Diller Family Comprehensive Cancer Center), Ritu Roy(University of California, San Francisco), Jennifer Bolen(UCSF Helen Diller Family Comprehensive Cancer Center), Mohammad Naser(University of California, San Francisco), Rachel A. O’Keefe(University of California, San Francisco), Danielle L. Swaney(Gladstone Institutes), Hua Li, Tian Ran Zhu(Xi'an Honghui Hospital), Kelechi Nwachuku, Antonio Jimeno(The Medical Center of Aurora), Gordon B. Mills(The University of Texas MD Anderson Cancer Center)
Cited by 19
Related Papers
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
|Nature|2008|7.8k
The Somatic Genomic Landscape of Glioblastoma
|Cell|2013|5.2k
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
|Science|2008|4k
Head and neck squamous cell carcinoma
|Nature Reviews Disease Primers|2020|4k